Adnane Mounir, Whiston Ronan, Tasara Taurai, Bleul Ulrich, Chapwanya Aspinas
Department of Biomedicine, Institute of Veterinary Sciences, University Ibn Khaldoun of Tiaret, Tiaret 14000, Algeria.
USDA, Faculty Exchange Program Fellow, University of Georgia, Athens, GA 30602, USA.
Animals (Basel). 2024 Apr 1;14(7):1073. doi: 10.3390/ani14071073.
Uterine disease in cattle impairs reproductive performance and profitability and increases antibiotic use and antimicrobial resistance. Thus, probiotics offer a promising alternative therapy. This review presents conceptual findings on the efficacy of probiotics in managing uterine diseases and fertility in cows. Probiotics containing spp. and spp. individually or as composite formulations are known to improve fertility. Strategic intravaginal administration of these formulations would likely enhance uterine immunity, particularly during the postpartum period. While current findings on the benefits to uterine health are encouraging, there is still significant knowledge missing, including a lack of empirical information from large-scale field trials. This review underscores the need for evidence-based guidelines for probiotics, such as genomic selection of formulations, targeted delivery, or potential synergy with other interventions. Future research should address these gaps to maximize the potential of probiotics in managing uterine diseases and enhancing the reproductive health of dairy cattle.
牛的子宫疾病会损害繁殖性能和盈利能力,并增加抗生素的使用和抗菌药物耐药性。因此,益生菌提供了一种有前景的替代疗法。本综述介绍了关于益生菌在管理奶牛子宫疾病和生育能力方面功效的概念性研究结果。已知含有 属和 属的益生菌单独使用或作为复合制剂可提高生育能力。这些制剂的策略性阴道内给药可能会增强子宫免疫力,尤其是在产后期间。虽然目前关于对子宫健康有益的研究结果令人鼓舞,但仍有大量知识缺失,包括缺乏来自大规模田间试验的实证信息。本综述强调了制定基于证据的益生菌指南的必要性,例如制剂的基因组选择、靶向递送或与其他干预措施的潜在协同作用。未来的研究应填补这些空白,以最大限度地发挥益生菌在管理子宫疾病和增强奶牛生殖健康方面的潜力。